Fabior Generic Name & Formulations
Tazarotene 0.1%; foam.
Fabior Dosage and Administration
Cleanse and dry affected area. Apply a thin layer to affected areas on face and/or upper trunk once daily in the PM. Women of childbearing potential: begin therapy during normal menses.
Fabior Boxed Warnings
Obtain reliable negative pregnancy test within 2 weeks before starting therapy; use effective contraception during therapy. Do not use on broken or eczematous skin. History of local hypersensitivity. Photosensitivity. History of skin cancer. Avoid eyes, lips, mouth, mucous membranes, sun and UV light; use adequate sun protection. Increased irritation in extreme weather. Discontinue if excessive local irritation occurs. Flammable. Nursing mothers: not recommended.
Cumulative irritant effect with concomitant other topical acne therapy; use caution. Avoid use until the effects of strong topical drying agents have subsided. Concomitant oxidizing agents (eg, benzoyl peroxide) may cause tazarotene degradation and reduce efficacy; apply at different times of the day (eg, AM & PM) if combination treatment is needed.
Fabior Adverse Reactions
Application site reactions (eg, irritation, dryness, erythema, exfoliation, pain, photosensitivity, pruritus, dermatitis).
Fabior Clinical Trials
Fabior Patient Counseling